386849001: Olanzapine (substance)

SNOMED CT Concept\Substance\...

\A grouper concept for substances that are used in medicinal products for medical treatment, and also psychoactive substances that have few or no legitimate medical uses or that are not legally available to the person using them.\Central nervous system agent (substance)\Psychoactive substance (substance)\Psychotropic agent (substance)\Anti-psychotic agent (substance)\Olanzapine (substance)

\Substance categorised by structure\Chemical\Chemical categorized by structure (substance)\Organic compound\Organic cyclic compound\Heterocyclic compound\Dibenzoxazepine compound (substance)\Olanzapine (substance)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2003. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module

1461027011 Olanzapine (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

1480964017 Olanzapine en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

4496751000005113 Olanzapin da Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) Danish module (core metadata concept)

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Olanzapine (substance)	Is a	antipsykotisk dibenzoxazepinderivat middel	false	Inferred relationship	Some
Olanzapine (substance)	Is a	Allergen class	false	Inferred relationship	Some
Olanzapine (substance)	Is a	Drug allergen	false	Inferred relationship	Some
Olanzapine (substance)	Is a	Dibenzoxazepine compound (substance)	true	Inferred relationship	Some
Olanzapine (substance)	Is a	Anti-psychotic agent (substance)	true	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Product containing olanzapine (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Olanzapine (substance)	Inferred relationship	Some	1
Olanzapine measurement (procedure)	Component	True	Olanzapine (substance)	Inferred relationship	Some	1
Olanzapine 5 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Olanzapine (substance)	Inferred relationship	Some
Olanzapine 7.5 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Olanzapine (substance)	Inferred relationship	Some
Olanzapine 10 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Olanzapine (substance)	Inferred relationship	Some
Olanzapine 2.5 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Olanzapine (substance)	Inferred relationship	Some
Olanzapine 5 mg orodispersible tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Olanzapine (substance)	Inferred relationship	Some
Product containing precisely olanzapine 10 milligram/1 each conventional release orodispersible tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Olanzapine (substance)	Inferred relationship	Some
Olanzapine 20 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Olanzapine (substance)	Inferred relationship	Some
Olanzapine 15 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Olanzapine (substance)	Inferred relationship	Some
Olanzapine 15mg disintergrating tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Olanzapine (substance)	Inferred relationship	Some
Olanzapine 20 mg orodispersible tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Olanzapine (substance)	Inferred relationship	Some
Olanzapine tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Olanzapine (substance)	Inferred relationship	Some
Olanzapine oral disintergrating tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Olanzapine (substance)	Inferred relationship	Some
Product containing precisely olanzapine 15 milligram/1 each conventional release orodispersible tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Olanzapine (substance)	Inferred relationship	Some
Product containing fluoxetine and olanzapine (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Olanzapine (substance)	Inferred relationship	Some	2
olanzapin 6 mg + fluoxetin 25 mg kapsel	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Olanzapine (substance)	Inferred relationship	Some
olanzapin 6 mg/fluoxetin 50 mg kapsel	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Olanzapine (substance)	Inferred relationship	Some
olanzapin 12 mg + fluoxetin 25 mg kapsel	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Olanzapine (substance)	Inferred relationship	Some
olanzapin 12 mg + fluoxetin 50 mg kapsel	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Olanzapine (substance)	Inferred relationship	Some
Olanzapine-containing product in parenteral dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Olanzapine (substance)	Inferred relationship	Some	1
olanzapin 10 mg pulver til injektionsvæske	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Olanzapine (substance)	Inferred relationship	Some
Product containing precisely olanzapine 15 milligram/1 each conventional release orodispersible tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Olanzapine (substance)	Inferred relationship	Some
Product containing olanzapine in oral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Olanzapine (substance)	Inferred relationship	Some	1
Product containing precisely fluoxetine hydrochloride 25 milligram and olanzapine 3 milligram/1 each conventional release oral capsule	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Olanzapine (substance)	Inferred relationship	Some
Olanzapine 300mg powder for injection suspension	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Olanzapine (substance)	Inferred relationship	Some
Olanzapine 210mg powder for injection suspension	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Olanzapine (substance)	Inferred relationship	Some
Olanzapine 405mg powder for injection suspension	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Olanzapine (substance)	Inferred relationship	Some
Olanzapine embonate (substance)	Is a	False	Olanzapine (substance)	Inferred relationship	Some
Olanzapine 5 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Olanzapine (substance)	Inferred relationship	Some	1
Olanzapine 5 mg oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Olanzapine (substance)	Inferred relationship	Some	1
Olanzapine 7.5 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Olanzapine (substance)	Inferred relationship	Some	1
Olanzapine 7.5 mg oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Olanzapine (substance)	Inferred relationship	Some	1
Olanzapine 10 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Olanzapine (substance)	Inferred relationship	Some	1
Olanzapine 10 mg oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Olanzapine (substance)	Inferred relationship	Some	1
Olanzapine 2.5 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Olanzapine (substance)	Inferred relationship	Some	1
Olanzapine 2.5 mg oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Olanzapine (substance)	Inferred relationship	Some	1
Olanzapine 20 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Olanzapine (substance)	Inferred relationship	Some	1
Olanzapine 20 mg oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Olanzapine (substance)	Inferred relationship	Some	1
Olanzapine 15 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Olanzapine (substance)	Inferred relationship	Some	1
Olanzapine 15 mg oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Olanzapine (substance)	Inferred relationship	Some	1
olanzapin 6 mg + fluoxetin 25 mg kapsel	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Olanzapine (substance)	Inferred relationship	Some	1
olanzapin 6 mg + fluoxetin 25 mg kapsel	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Olanzapine (substance)	Inferred relationship	Some	1
olanzapin 6 mg/fluoxetin 50 mg kapsel	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Olanzapine (substance)	Inferred relationship	Some	1
olanzapin 6 mg/fluoxetin 50 mg kapsel	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Olanzapine (substance)	Inferred relationship	Some	1
olanzapin 12 mg + fluoxetin 25 mg kapsel	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Olanzapine (substance)	Inferred relationship	Some	2
olanzapin 6 mg + fluoxetin 25 mg kapsel	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Olanzapine (substance)	Inferred relationship	Some	2
Product containing precisely fluoxetine hydrochloride 25 milligram and olanzapine 3 milligram/1 each conventional release oral capsule	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Olanzapine (substance)	Inferred relationship	Some	1
Product containing precisely fluoxetine hydrochloride 25 milligram and olanzapine 3 milligram/1 each conventional release oral capsule	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Olanzapine (substance)	Inferred relationship	Some	1
olanzapin 12 mg + fluoxetin 50 mg kapsel	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Olanzapine (substance)	Inferred relationship	Some	1
olanzapin 12 mg + fluoxetin 50 mg kapsel	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Olanzapine (substance)	Inferred relationship	Some	1
olanzapin 12 mg + fluoxetin 25 mg kapsel	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Olanzapine (substance)	Inferred relationship	Some	1
olanzapin 12 mg + fluoxetin 25 mg kapsel	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Olanzapine (substance)	Inferred relationship	Some	1
Olanzapine pamoate	Is a	False	Olanzapine (substance)	Inferred relationship	Some
Olanzapine 5 mg oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Olanzapine (substance)	Inferred relationship	Some	1
Olanzapine 7.5 mg oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Olanzapine (substance)	Inferred relationship	Some	1
Olanzapine 10 mg oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Olanzapine (substance)	Inferred relationship	Some	1
Product containing precisely fluoxetine hydrochloride 25 milligram and olanzapine 3 milligram/1 each conventional release oral capsule	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	False	Olanzapine (substance)	Inferred relationship	Some	1
Olanzapine 2.5 mg oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Olanzapine (substance)	Inferred relationship	Some	1
olanzapin 6 mg + fluoxetin 25 mg kapsel	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	False	Olanzapine (substance)	Inferred relationship	Some	2
olanzapin 12 mg + fluoxetin 25 mg kapsel	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	False	Olanzapine (substance)	Inferred relationship	Some	2
Olanzapine 20 mg oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Olanzapine (substance)	Inferred relationship	Some	1
Olanzapine 15 mg oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Olanzapine (substance)	Inferred relationship	Some	1
olanzapin 6 mg/fluoxetin 50 mg kapsel	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	False	Olanzapine (substance)	Inferred relationship	Some	1
olanzapin 12 mg + fluoxetin 50 mg kapsel	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	False	Olanzapine (substance)	Inferred relationship	Some	1
Fluoxetine- and olanzapine-containing product in oral dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Olanzapine (substance)	Inferred relationship	Some	2
Product containing only olanzapine (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Olanzapine (substance)	Inferred relationship	Some	1
Product containing only fluoxetine and olanzapine (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Olanzapine (substance)	Inferred relationship	Some	2
Olanzapine only product in parenteral dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Olanzapine (substance)	Inferred relationship	Some	1
Product containing only olanzapine in oral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Olanzapine (substance)	Inferred relationship	Some	1
Fluoxetine and olanzapine only product in oral dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Olanzapine (substance)	Inferred relationship	Some	2
Olanzapine embonate (substance)	This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged.	True	Olanzapine (substance)	Inferred relationship	Some
Olanzapine pamoate	This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged.	False	Olanzapine (substance)	Inferred relationship	Some
Olanzapine 5 mg orodispersible tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Olanzapine (substance)	Inferred relationship	Some	1
Olanzapine 5 mg orodispersible tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Olanzapine (substance)	Inferred relationship	Some	1
Product containing precisely olanzapine 10 milligram/1 each conventional release orodispersible tablet (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Olanzapine (substance)	Inferred relationship	Some	1
Product containing precisely olanzapine 10 milligram/1 each conventional release orodispersible tablet (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Olanzapine (substance)	Inferred relationship	Some	1
Product containing precisely olanzapine 15 milligram/1 each conventional release orodispersible tablet (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Olanzapine (substance)	Inferred relationship	Some	1
Product containing precisely olanzapine 15 milligram/1 each conventional release orodispersible tablet (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Olanzapine (substance)	Inferred relationship	Some	1
Olanzapine 20 mg orodispersible tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Olanzapine (substance)	Inferred relationship	Some	1
Olanzapine 20 mg orodispersible tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Olanzapine (substance)	Inferred relationship	Some	1
Product containing olanzapine in oromucosal dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Olanzapine (substance)	Inferred relationship	Some	1
Product containing only olanzapine in oromucosal dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Olanzapine (substance)	Inferred relationship	Some	1
Product containing precisely fluoxetine (as fluoxetine hydrochloride) 25 milligram and olanzapine 12 milligram/1 each conventional release oral capsule (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Olanzapine (substance)	Inferred relationship	Some	2
Product containing precisely fluoxetine (as fluoxetine hydrochloride) 25 milligram and olanzapine 12 milligram/1 each conventional release oral capsule (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Olanzapine (substance)	Inferred relationship	Some	2
Product containing precisely fluoxetine (as fluoxetine hydrochloride) 25 milligram and olanzapine 6 milligram/1 each conventional release oral capsule (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Olanzapine (substance)	Inferred relationship	Some	2
Product containing precisely fluoxetine (as fluoxetine hydrochloride) 25 milligram and olanzapine 6 milligram/1 each conventional release oral capsule (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Olanzapine (substance)	Inferred relationship	Some	2
Product containing precisely fluoxetine (as fluoxetine hydrochloride) 25 milligram and olanzapine 3 milligram/1 each conventional release oral capsule (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Olanzapine (substance)	Inferred relationship	Some	2
Product containing precisely fluoxetine (as fluoxetine hydrochloride) 25 milligram and olanzapine 3 milligram/1 each conventional release oral capsule (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Olanzapine (substance)	Inferred relationship	Some	2
Fluoxetine (as fluoxetine hydrochloride) 50 mg and olanzapine 6 mg oral capsule	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Olanzapine (substance)	Inferred relationship	Some	2
Fluoxetine (as fluoxetine hydrochloride) 50 mg and olanzapine 6 mg oral capsule	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Olanzapine (substance)	Inferred relationship	Some	2
Product containing precisely fluoxetine (as fluoxetine hydrochloride) 50 milligram and olanzapine 12 milligram/1 each conventional release oral capsule (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Olanzapine (substance)	Inferred relationship	Some	2
Product containing precisely fluoxetine (as fluoxetine hydrochloride) 50 milligram and olanzapine 12 milligram/1 each conventional release oral capsule (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Olanzapine (substance)	Inferred relationship	Some	2
Olanzapine 10 mg powder for solution for injection vial	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Olanzapine (substance)	Inferred relationship	Some	1
Olanzapine 10 mg powder for solution for injection vial	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Olanzapine (substance)	Inferred relationship	Some	1
Product containing precisely olanzapine (as olanzapine embonate) 405 milligram/1 vial powder for prolonged-release suspension for injection (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Olanzapine (substance)	Inferred relationship	Some	1
Olanzapine (as olanzapine embonate) 300 mg powder for prolonged-release suspension for injection vial	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Olanzapine (substance)	Inferred relationship	Some	1
Product containing precisely olanzapine (as olanzapine embonate) 210 milligram/1 vial powder for prolonged-release suspension for injection (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Olanzapine (substance)	Inferred relationship	Some	1

Reference Sets

GB English

US English

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
1461027011	Olanzapine (substance)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
1480964017	Olanzapine	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
4496751000005113	Olanzapin	da	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	Danish module (core metadata concept)